Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Atrial Fibrillation
100%
Direct Oral Anticoagulant
80%
Antithrombotic
57%
Observational Study
57%
Vitamin K Antagonist
57%
Systematic Review
57%
Apoplexy
49%
Cohort Analysis
38%
General Medicine
38%
Meta-Analysis
38%
Warfarin
25%
Anticoagulant
19%
Prognostication
19%
Collaborative Learning
19%
Clinical Trial Design
19%
Health Service
19%
Artificial Intelligence
19%
Major Bleeding
16%
Randomized Controlled Trial
16%
Brain Ischemia
16%
Cerebral Hemorrhage
13%
Anticoagulation
12%
Adverse Event
9%
Myocardial Infarction
7%
Bleeding
7%
Attributable Risk
6%
Gastrointestinal Bleeding
5%
Nursing and Health Professions
Anticoagulant Agent
95%
Atrial Fibrillation
80%
Cerebrovascular Accident
44%
General Practice
38%
Cohort Analysis
38%
Antivitamin K
38%
Systematic Review
38%
Warfarin
25%
Clinical Practice
21%
Meta Analysis
19%
Older Person
19%
Anticoagulation
11%
Brain Ischemia
9%
Bleeding
9%
Medline
9%
Scopus
9%
Adverse Event
7%
Attributable Risk
5%
Brain Hemorrhage
5%
Pharmacology, Toxicology and Pharmaceutical Science
Atrial Fibrillation
80%
Direct Oral Anticoagulant
60%
Anticoagulant Agent
57%
Cerebrovascular Accident
44%
Cohort Study
38%
Antivitamin K
38%
Observational Study
38%
Warfarin
25%
Randomized Controlled Trial
12%
Brain Ischemia
9%
Bleeding
9%
Adverse Event
7%
Brain Hemorrhage
5%